The decrease in the CD4+ T cell levels, on the other hand, is in correlation with ALS progression and it was suggested that the reduced T cell amount may represent the decreased neuroprotection during ALS progression (Murdock et al., 2017). The gene discussed is CD4; the disease is amyotrophic lateral sclerosis.